AMT Intends to Incorporate Additional Data to its Marketing Authorization Dossier for Glybera(R)
AMSTERDAM, October 3 /PRNewswire/ -- Amsterdam Molecular Therapeutics (Euronext: AMT), a leader in the field of human gene therapy, announced today that it intends to incorporate additional data…